Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117848572 | 11784857 | 2 | F | 20160831 | 20151130 | 20160902 | EXP | CA-ROCHE-1667774 | ROCHE | 67.00 | YR | F | Y | 0.00000 | 20160902 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117848572 | 11784857 | 1 | PS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | U | 50723 | 180 | MG | TABLET | BID | ||||||
| 117848572 | 11784857 | 2 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | U | 50723 | 1 | DF | TABLET | QD | ||||||
| 117848572 | 11784857 | 3 | SS | IRBESARTAN. | IRBESARTAN | 1 | Oral | U | 0 | 37.5 | MG | TABLET | QD | ||||||
| 117848572 | 11784857 | 4 | SS | RAPAMUNE | SIROLIMUS | 1 | Oral | U | 0 | 3 | MG | QD | |||||||
| 117848572 | 11784857 | 5 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | U | N | 0 | |||||||||
| 117848572 | 11784857 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 117848572 | 11784857 | 7 | C | APO-SULFATRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 0 | 400 | MG | QD | ||||||||
| 117848572 | 11784857 | 8 | C | BISOPROLOL | BISOPROLOL | 1 | Oral | 0 | 2.5 | MG | QD | ||||||||
| 117848572 | 11784857 | 9 | C | CIPROFLOXACIN HYDROCHLORIDE. | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | |||||||||
| 117848572 | 11784857 | 10 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | Oral | 0 | 60 | MG | CAPSULE | QD | |||||||
| 117848572 | 11784857 | 11 | C | MYCOPHENOLIC ACID. | MYCOPHENOLIC ACID | 1 | Unknown | 0 | 1 | DF | QD | ||||||||
| 117848572 | 11784857 | 12 | C | RISEDRONATE | RISEDRONATE SODIUM | 1 | Oral | 0 | 35 | MG | TABLET | /wk | |||||||
| 117848572 | 11784857 | 13 | C | SODIUM FLUORIDE. | SODIUM FLUORIDE | 1 | Unknown | 0 | |||||||||||
| 117848572 | 11784857 | 14 | C | VALGANCICLOVIR HYDROCHLORIDE. | VALGANCICLOVIR HYDROCHLORIDE | 1 | Unknown | 0 | 450 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117848572 | 11784857 | 1 | Immunosuppressant drug therapy |
| 117848572 | 11784857 | 3 | Blood pressure abnormal |
| 117848572 | 11784857 | 4 | Product used for unknown indication |
| 117848572 | 11784857 | 5 | Product used for unknown indication |
| 117848572 | 11784857 | 6 | Product used for unknown indication |
| 117848572 | 11784857 | 8 | Product used for unknown indication |
| 117848572 | 11784857 | 9 | Product used for unknown indication |
| 117848572 | 11784857 | 10 | Product used for unknown indication |
| 117848572 | 11784857 | 11 | Product used for unknown indication |
| 117848572 | 11784857 | 12 | Product used for unknown indication |
| 117848572 | 11784857 | 13 | Product used for unknown indication |
| 117848572 | 11784857 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117848572 | 11784857 | HO |
| 117848572 | 11784857 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117848572 | 11784857 | Abdominal discomfort | |
| 117848572 | 11784857 | Abdominal pain | |
| 117848572 | 11784857 | Blood creatinine increased | |
| 117848572 | 11784857 | Blood disorder | |
| 117848572 | 11784857 | Blood iron decreased | |
| 117848572 | 11784857 | Blood pressure decreased | |
| 117848572 | 11784857 | Chest discomfort | |
| 117848572 | 11784857 | Cough | |
| 117848572 | 11784857 | Diarrhoea | |
| 117848572 | 11784857 | Discomfort | |
| 117848572 | 11784857 | Dizziness | |
| 117848572 | 11784857 | Drug administered to patient of inappropriate age | |
| 117848572 | 11784857 | Dysphonia | |
| 117848572 | 11784857 | Dyspnoea exertional | |
| 117848572 | 11784857 | Faeces soft | |
| 117848572 | 11784857 | Fatigue | |
| 117848572 | 11784857 | Haemoglobin decreased | |
| 117848572 | 11784857 | Infection in an immunocompromised host | |
| 117848572 | 11784857 | Joint swelling | |
| 117848572 | 11784857 | Musculoskeletal stiffness | |
| 117848572 | 11784857 | Nasopharyngitis | |
| 117848572 | 11784857 | Nausea | |
| 117848572 | 11784857 | Oedema peripheral | |
| 117848572 | 11784857 | Oropharyngeal pain | |
| 117848572 | 11784857 | Pain | |
| 117848572 | 11784857 | Peripheral swelling | |
| 117848572 | 11784857 | Pyrexia | |
| 117848572 | 11784857 | Rhinorrhoea | |
| 117848572 | 11784857 | Swelling face | |
| 117848572 | 11784857 | Viral infection | |
| 117848572 | 11784857 | Weight decreased | |
| 117848572 | 11784857 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |